Elimination of Hexamethylene Diisocyanate Cross-linked Polypeptides in Patients with Normal or Impaired Renal Function

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1978 Dec 18

PMID 738348

Citations 1

Authors

H Kohler

W Kirch

P Fuchs

K Stalder

A Distler

Affiliations

Soon will be listed here.

Citing Articles

[The elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine (author's transl)].

Kohler H, Zschiedrich H, Linfante A, Appel F, Pitz H, CLASEN R Klin Wochenschr. 1982; 60(6):293-301.

PMID: 6176754 DOI: 10.1007/BF01716806.

References

ARTRUSON G, Granath K, Thoren L, WALLENIUS G . THE RENAL EXCRETION OF LOW MOLECULAR WEIGHT DEXTRAN. Acta Chir Scand. 1964; 127:543-51. View

Hart W, Duursma S, Visser W, Njio L . The hydroxyproline content of plasma of patients with impaired renal function. Clin Nephrol. 1975; 4(3):104-8. View

SCHWARTZKOPFF W, Seidel M, Kunkel G, FALCK I . [Clinical and experimental studies on a gelatin plasma expander with special reference to renal hemodynamics in normovolemic and hypovolemic subjects]. Z Gesamte Exp Med Einschl Exp Chir. 1968; 147(3):202-35. View

STEGEMANN H . [Microdetermination of hydroxyproline with chloramine-T and p-dimethylaminobenzaldehyde]. Hoppe Seylers Z Physiol Chem. 1958; 311(1-3):41-5. View

Burkhardt H, Burkhardt F, Rommel K . [Estimation of collagen metabolism with the hypronosticon test (author's transl)]. Dtsch Med Wochenschr. 1973; 98(40):1847-8 passim. DOI: 10.1055/s-0028-1107142. View

STEGEMANN H, Stalder K . Determination of hydroxyproline. Clin Chim Acta. 1967; 18(2):267-73. DOI: 10.1016/0009-8981(67)90167-2. View

Kohler H, Kirch W, Hoffler D, Koeppe P . [Pharmacocinetics and dosage of dextran 40 in relation to renal function (author's transl)]. Klin Wochenschr. 1974; 52(23):1111-6. DOI: 10.1007/BF01468621. View

Zekorn D . Intravascular retention, dispersal, excretion and break-down of gelatin plasma substitutes. Bibl Haematol. 1969; 33:131-40. DOI: 10.1159/000384835. View

SCHMIDT-THOME J, Mager A, SCHOENE H . [On the chemistry of a new plasma expander]. Arzneimittelforschung. 1962; 12:378-80. View

10.

KIEF H, ENGELBART K . [Reabsorptive vacuolization of the contorted main parts of the kidney (so-called osmotic nephrosis)]. Frankf Z Pathol. 1966; 75(1):53-65. View

11.

Metcalf W, Papadopoulos A, Tufaro R, Barth A . A clinical physiologic study of hydroxyethyl starch. Surg Gynecol Obstet. 1970; 131(2):255-67. View

12.

Milutinovic J, Cutler R, Hoover P, Meijsen B, Scribner B . Measurement of residual glomerular filtration rate in the patient receiving repetitive hemodialysis. Kidney Int. 1975; 8(3):185-90. DOI: 10.1038/ki.1975.98. View

13.

Schiessl J, Schweigart U, Bottermann P, Kopp K . [Hydroxyproline in the dialysate as a parameter of secondary hyperparathyroidism. Effects of phosphate reduction and alkalization]. Verh Dtsch Ges Inn Med. 1977; 83:1310-3. View

14.

Kohler H, Weihrauch T, Fiegel P, Kirch W, Hoffler D . [Dosage and elimination of Dextran 40 in patients on hemodialysis (author's transl)]. Klin Wochenschr. 1975; 53(11):523-7. DOI: 10.1007/BF01468757. View

15.

GRIEM W, CZOK G, Lang K . [HISTOLOGICAL AND PHYSIOLOGICAL STUDIES ON RATS AFTER HAEMACCEL AND RAT SERUM INJECTIONS]. Anaesthesist. 1964; 13:324-30. View

16.

Kohler H, Kirch W, Vogt J, Hoffler D . [Pharmacokinetics of hydroxyethyl starch in kidney failure]. Verh Dtsch Ges Inn Med. 1977; 83:1676-8. View

17.

Dubovsky J, DUBOVSKA E, Pacovsky V, Hrba J . Free and peptide hydroxyproline in chronic uremia. Clin Chim Acta. 1968; 19(3):387-90. DOI: 10.1016/0009-8981(68)90263-5. View